Saniona AB

Saniona

Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. Saniona has four programs in clinical development including three late stage clinical programs focused on the development of treatments to effectively regulate …

In addition to the active pipeline shown above, Saniona has a range a range …

SANION:Stockholm Stock Quote – Saniona AB – …

Stock analysis for Saniona AB (SANION:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Saniona AB – bloomberg.com

About Saniona AB Saniona AB researches and develops drugs to treat diseases of the central nervous system, autoimmune diseases, and for pain relief. The Company collaborates with global pharmaceutical companies to develop drugs …

Saniona AB, SANION:STO summary – FT.com

Saniona AB is a Sweden-based company active in the field of biotechnology. It operates in the area of drugs targeting ion channels to develop therapeutics for pain, central nervous system, and inflammatory or autoimmune disea ses.

Saniona AB (publ) (STO:SANION): Is Now The Time To …

Saniona AB (publ) , a KR637.46M small-cap, is a healthcare company operating in an industry, which faces demand for new drug development to meet new or persistent chronic illnesses, and ongoing need for biotech drugs as Baby Boomers continue to age. Healthcare analysts are forecasting for the entire industry, a strong double-digit growth …

Saniona AB – kurs, graf, nyheder, nøgletal og anbefalinger

Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases and the treatment of pain. The company develops a technology platform which enables investigation of all types of ion channel drug targets.

Saniona AB: Saniona announces a merger of its spinout

Saniona AB: Saniona announces a merger of its spinout company Ataxion with Luc Therapeutics. Email Print Friendly Share. Saniona is listed at Nasdaq First North Premier and has about 4,500

Saniona AB – reportbuyer.com

A textual analysis of the financial results for Saniona AB compared to selected competitors.